Cell Therapy in Idiopathic Pulmonary Fibrosis†
AbstractIdiopathic pulmonary fibrosis is a fatal disease with no effective or curative treatment options. In recent decades, cell-based therapies using stem cells or lung progenitor cells to regenerate lung tissue have experienced rapid growth in both preclinical animal models and translational clinical studies. In this review, the current knowledge of these cell therapies is summarized. Although further investigations are required, these studies indicate that cell therapies are a promising therapeutic approach for the treatment of idiopathic pulmonary fibrosis. View Full-Text
Share & Cite This Article
Serrano-Mollar, A. Cell Therapy in Idiopathic Pulmonary Fibrosis†. Med. Sci. 2018, 6, 64.
Serrano-Mollar A. Cell Therapy in Idiopathic Pulmonary Fibrosis†. Medical Sciences. 2018; 6(3):64.Chicago/Turabian Style
Serrano-Mollar, Anna. 2018. "Cell Therapy in Idiopathic Pulmonary Fibrosis†." Med. Sci. 6, no. 3: 64.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.